Dexcom | DXCM - Zahlungsmittel Und Äquivalente

Aktienkurs
63.97
Täglich Wechseln
-1.71 -2.60%
Monatlich
-3.53%
Jährlich
-3.28%
Q2 Prognose
60.35




Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 8.52B 1.01B 2025-12
Align Technology USD 1B 103.43M 2025-09
AtriCure USD 167.43M 19.56M 2025-12
Avanos Medical USD 89.8M 19.3M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Globus Medical USD 526.16M 154.39M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
J&J USD 19.71B 1.48B 2025-12
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Solventum Corp USD 878M 764M 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
West Pharmaceutical Services USD 791.3M 162.8M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12